ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,322, issued on Dec. 2, was assigned to Annexon Inc. (Brisbane, Calif.).
"Anti-complement factor C1q antibodies with single binding arms and uses thereof" was invented by Ted Yednock (Forest Knolls, Calif.) and Sethu Sankaranarayanan (Fremont, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to antibodies with a single antigen-binding arm comprising a single antigen-binding arm and an Fc region such as a single-arm antibodies. The present disclosure also relates generally to the use of such antibodies such as treating a disease associated with complement activation."
The patent was filed on Dec. 13, 2022,...